Document:

Exhibit 10.33.3

AMENDMENT TO AGREEMENT

          Spencer Trask Private Equity Fund I LP, Spencer Trask Private Equity Fund II LP, Spencer Trask Specialty Group, LLC, Kevin Kimberlin Partners LP and NuVim, Inc. agree to further amend their December 31, 2004 agreement, as previously amended on March 28, 2005 and May 2, 2005, as follows:

          The reference to an $8.1 million offering of units of consisting of one share of common stock, one Class A Warrant and one Class B Warrant at an initial public offering price of $3 is hereby changed, modified and amended to refer to a $2.7 million offering of 2,700,000 units, each unit consisting of one share of common stock, one Class A warrant and one B Class B warrant at an initial public offering price of $1.00 per unit.

          The reference in the agreement to a closing date of May 31, 2005 is hereby changed, modified and amended to refer to a close date of June 30, 2005.

          The remainder of the December 31, 2004 agreement, as previously amended on March 28, 2005 and May 2, 2005, remains in full force and effect.

          Dated this 18th day of May, 2005.

	
  
SPENCER TRASK   PRIVATE EQUITY   FUND I LP
  	
  
 
  	
  
SPENCER TRASK   PRIVATE EQUITY   FUND II LP
  
	
   
  	
  
 
  	
  
 
  
	
  
By:  /s/ WILLIAM   P. DIOGUARDI
  	
  
 
  	
  
By:  /s/ WILLIAM   P. DIOGUARDI
  
	
  

  	
  
 
  	
  

  
	
  
Print Name   and Title:
  	
  
 
  	
  
Print Name   and Title:
  
	
  
 
  	
  
 
  	
  
 
  
	
  
SPENCER TRASK SPECIALTY GROUP LLC
  	
  
 
  	
  
KEVIN KIMBERLIN PARTNERS LP
  
	
  
 
  	
  
 
  	
  
 
  
	
  By:  /s/ DONALD   F. FARLEY
  	
  
 
  	
  
By:  /s/ KEVIN   KIMBERLIN
  
	
  

  	
  
 
  	
  

  
	
  
Print Name   and Title:
  	
  
 
  	
  
Print Name   and Title:
  

	
  
NUVIM, INC.
  	
  
 
  
	
  
 
  	
  
 
  
	
  
By:  /s/ RICHARD   P. KUNDRAT
  	
  
 
  
	
  

  	
   
  
	
  Print Name   and Title: Richard P. Kundrat
  	
   
  
	
  Chairman and   Chief Executive OfficerExhibit 10.35.2

AMENDMENT OF
 MARCH 28, 2005
 MODIFICATION AND EXTENSION AGREEMENT

          WHEREAS, Stolle Milk Biologics, Inc. (“SMBI”), a Delaware corporation, and NuVim, Inc. (“NuVim”), a Delaware corporation, entered into a variety of agreements detailed with the parties’ Modification and Extension Agreement dated as of March 28, 2005 (the “Agreement”)and,

          WHEREAS, the Agreement specified that there existed an amount of arrears existing under prior Supply and/or License Agreements (“Receivables Balance”) of $352,277.76, an amount of arrears existing for assignment of the NuVim Trademark (“Deferral Balance”) of $60,000.00, and the additional sum of $40,000 (“.Interest Payment”) and that said sums were to be paid by NuVim to SMBI by certain dates,

          NOW, THEREFORE, in consideration of the mutual covenants and promises set forth herein, the parties hereto hereby agree as follows:

          1.          That the Agreement is further modified and amended to the extent that NuVim will pay to SMBI the sum of $250,000.00 within the earlier of (a) two business days after the completion by NuVim of its pending Initial Public Offering (“IPO”) and NuVim’s receipt of such funds from the underwriter of the IPO, or (b) June 30, 2005, with said sum to be first applied towards reduction of the Deferral Balance and then towards reduction of the Receivables Balance,

          2.          In exchange therefor, subject to upon compliance with Paragraph 3 below. SMBI shall notify Escrowee of such -receipt of the $250,000,00 and cause to have delivered, and Escrowee hereinafter mentioned shall deliver, to Nuvim, within three business days after said receipt (from either SMBI or NuVim), the Trademark Assignments of the NuVim Trademark to NuVim in the form annexed hereto as Exhibits A-1 and A-2. Such Trademark Assignments are conditioned upon the timely payment in full of the amounts set forth in Paragraph 3 below. Upon their execution of this Amendment, each party hereto agrees to immediately execute the Trademark Assignments and forward them to Escrowee.

          3.          In addition, the remainder of the Receivables Balance ($162,277.76) and the Interest Payment ($40,000.00) for a total of $202,277.76 shall be paid by NuVim to SMBI on or before January 16, 2006. In the event such payment is timely made, it shall be deemed to be payment in full by NuVim of the Receivables Balance and all interest accrued thereon or interest accrued under the License Agreement, the Supply Agreement, the Consent, the Deferral Agreement or the-Modification and Extension Agreement through such payment date. In the event the provisions of this Paragraph 3 are not timely or fully complied with, then the Trademark Assignments shall terminate and be automatically null and void, the Trademark shall immediately revert to SMBI, and NuVim will execute any documents necessary or desirable to effectuate such result. 

          The parties agree that this Amendment of March 28, 2005 Modification and Extension Agreement may be executed in counterparts and via facsimile oz email transmission.

             IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment as of May 26, 2005.

	
  
NUVIM, INC.
  	
  
 
  	
  
STOLLE MILK BIOLOGICS, INC.
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
By:
  	
  
/s/ RICHARD P. KUNDRAT
  	
  
 
  	
  
By:
  	
  
/s/ C.F. STERLING, JR.
  
	
  
 
  	
  

  	
  
 
  	
  
 
  	
  

  
	
  
Name:
  	
  
Richard   Kundrat
  	
  
 
  	
  
Name:
  	
  
Con F.   Sterling, Jr.
  
	
  
Title:
  	
  
President
  	
  
 
  	
  
Title:
  	
  
President
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
GRAYDON HEAD & RITCHEY LLP,
  	
  
 
  	
  
 
  	
  
 
  
	
  
Escrowee,   solely for the purposes of Section 2 above
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
   
  	
   
  	
   
  	
   
  
	
  By:
  	
  /s/ MICHAEL A. HIRSCHFELD
  	
   
  	
   
  	
   
  
	
   
  	
  

  	
   
  	
   
  	
   
  
	
   
  	
  Michael A.   Hirschfeld, PartnerEXHIBIT 10.36.2

          AMENDED & RESTATED CONVERSION AGREEMENT dated as of May 31, 2005, between DICK CLARK (“Lender”), and NUVIM, INC. (“Borrower”).

W I T N E S S E T H

          WHEREAS, Borrower is the exclusive distributor of the “NuVim” drink supplement and the exclusive licensee of the “NuVim” trademark; and

          WHEREAS, Lender has lent One Million ($1,000,000) Dollars (the “Loan”) to Borrower under certain terms and conditions, and has received from Borrower a series of Notes with respect to the Loan; and

          WHEREAS, Lender and/or its assignee is owed under the Notes the principal sum of $1,000,000.00 plus accrued interest, penalty interest, costs and expenses, for a total of $1,084,146.00 due through the date hereof (“Amount Due”); and

          WHEREAS, Borrower’s initial public offering of securities registered on Form SB-2 (File No. 333-120938) (“IPO”) has been delayed; and

          WHEREAS, Borrower and Lender entered into a Conversion Agreement dated April 30, 2005, which Conversion Agreement is of no force and effect and is superseded, amended and restated in its entirety by this Agreement; and 

          WHEREAS, Borrower has requested that Lender convert $500,000 of the Amount Due to common stock of Borrower, extend the due date on the balance of the Amount Due, and amend the interest rate with respect to the Amount Due, and Lender is willing to do so, on the terms and conditions set forth herein:

          NOW, THEREFORE, in consideration of the foregoing and the mutual promises contained herein and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged by the parties hereto, the parties hereto covenant and agree as follows:  

          1.          Subject to the terms and conditions of this Agreement, Lender agrees: (a) to convert and exchange $500,000.00 of the Amount Due to Lender under its Note(s) (the “Conversion Amount”) for 250,000 shares of NuVim Common Stock at the agreed upon price of $2.00 per share, provided that the following conditions precedent are satisfied: (i) the 250,000 shares of NuVim Common Stock are issued to Lender and/or its assignee, (ii) in connection with the successful public sale (i.e., going effective and closing) of the Borrower’s stock in accordance with the IPO on or before June 30, 2005, and (iii) said shares are concurrently registered for resale, subject only to the lock-up period described in Section 2 of this Agreement, (b), with respect to the remaining balance of the Amount Due to Lender under the Notes(s), to extend the due date to
the earlier of 18 months from the date hereof or the date of a subsequent stock sale, sale of assets, change of control or financing (the “Extended Due Date”), and (c) to reduce the rate of interest on the remaining Amount Due to eight (8%) percent for the period commencing on the date hereof to the Extended Due Date.

          2.          Lender (and its assignee) agrees that the Shares of NuVim Common Stock received in exchange for the Conversion Amount may not be publicly sold pursuant to the resale prospectus for a period of six months following the effective date of the registration statement referred to above.

          3.          In the event the IPO does not go effective at the price per unit of $1.00 and actually close by June 30, 2005, Lender shall have no obligation to convert the Conversion Amount into common stock of the Borrower, extend the due date under said Note(s), or modify the interest rate.  Nothing contained in this Agreement, other than as specifically set forth in Section 1 above after satisfaction of the conditions set forth therein, shall impact upon, affect or alter Lender’s rights and remedies under the Loan Agreement or the Security Agreement, or its secured creditor position or priority.

          4.          Borrower hereby represents, warrants and covenants that: (a) no other current debt holder of Borrower (other than employees Rick Kundrat, John Sullivan and Paul Young, as to their accrued salaries aggregating $79,167.00 for April and May, 2005 which are converting at $1.00 per share) is being granted conversion terms that are superior to the terms set forth in this Agreement, including with respect to the price per share, the instruments into which the debt is converted, or the hold-back period; (b) it will file its periodic reports with the Securities and Exchange Commission (“SEC”) so as to satisfy the requirements under Rule 144, as well as any other SEC requirement; and (c) it will promptly remove any restrictive legend for the Common Stock issued hereunder on the first day after the expiration of the period described in
Section 2 of this Agreement.

          5.          This Agreement may be executed in counterpart and via facsimile or email transmission.

          IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be executed by their respective duly authorized officer or member as of the date first above written.

	
  
 
  	
  
NUVIM, INC.
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  By:
  	
  /s/ MICHAEL VESEY
  
	
   
  	
   
  	
  

  
	
   
  	
  Name:
  	
  Michael Vesey
  
	
   
  	
  Title:
  	
  Chief   Financial Officer
  
	
   
  	
   
  	
   
  
	
   
  	
  /s/ DICK CLARK   
  
	
   
  	
  

  
	
   
  	
  Dick Clark   by Fran La Maina, as Attorney-in-Fact

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]